TheIMPT.org
  • About
    ▲
    • What We Do
    • Who We Are
    • What is the IMPT?
      ▲
      • History of the IMPT
    • What are MPTs?
    • FAQs
  • Resources
    ▲
    • Resource Search
    • Databases
      ▲
      • MPT Product Database
      • Women’s Health Impact Catalyst
      • STI Database (Coming Soon)
    • Digital Stories
    • IMPT Newsletter
    • Let’s Talk MPTs Webinars
    • Knowledge Hubs
      ▲
      • Advocacy Hub
      • MPT Regulatory Guidance Hub
      • Socio-behavioral Research Hub
    • MPT Funding Opportunities
    • MPT Trainee & Career Resources
    • MPT Fieldwide Action Areas
    • Events and more
      ▲
      • Upcoming Conferences and Events
      • MPT Summit 2024
  • Get Involved
    ▲
    • Donate
    • Subscribe to our Mailing List
  • Contact Us
  • Donate
Skip to content
The IMPT Logo
  • About
    • Who We Are
    • What is the IMPT?
      • History of the IMPT
    • What are MPTs?
    • FAQs
  • Resources
    • Resource Search
    • Databases
      • MPT Product Database
      • Women’s Health Impact Catalyst
      • STI Database (Coming Soon)
    • Digital Stories
    • Let’s Talk MPTs Webinars
    • Knowledge Hubs
      • Advocacy Hub
      • MPT Regulatory Guidance Hub
      • Socio-behavioral Research Hub
    • IMPT Newsletter
    • MPT Funding Opportunities
    • MPT Trainee & Career Resources
    • MPT Fieldwide Action Areas
    • Events and more
      • Upcoming Conferences and Events
      • MPT Summit 2024
  • Get Involved
    • Donate
    • Subscribe to our Mailing List
  • Contact
  • Donate
  • Menu

News by Tag

News tags: female condom

FROM THE PIPELINE | The road to female controlled prevention: The female condom as a currently available MPT

February 26, 2018

The Road 6 years; 12 Million Dollars. When the founders of the Female Health Company (FHC) began conceptualizing the female condom in 1996, they wanted to create a product that would impact society as well as benefit investors. Little did they know that it would be a long road to develop a market for the […]


Back to News Index
Join Our Email List

The “MPT Insider” provides you the latest updates, trends, and opportunities for all things multipurpose prevention technologies (MPTs). These issues are released at least once per quarter, and resources highlighted in each issue are added to the MPT Resource Center. Browse our archives!

Any thoughts?

Contact us to learn more about the submission process.

Recent Posts

  • Meet the 2023 intern: Jason Trang
  • Integrating End-User Research in MPT Product Development and Commercialization Strategies: Post-Webinar Discussion
  • Building on the Self-Care Movement: Advances in Sexual and Reproductive Health
  • Meet the 2021 interns: Madison Langrin
  • Meet the 2021 interns: Hannah Rubens

News tags

contraception contraceptive Development end-user HIV IMPT Team innovation learning network multidisciplinary collaboration network pipeline prevention product product development protection Reproductive Health socio-behavioral research SRH STIs women

DONATE

IMPT Secretariat
Headquarters
1950 Franklin Street, #600
Oakland, CA 94612
Phone: 510.285.5500
Fax: 510.285.5501
IMPT@cami-health.org
Contact Us

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the National Institutes of Health (NIH) through contracts #75N94023P00822. The contents of this website are the sole responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of NIH or the United States Government.


© Copyright 2026, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.

  • Public Heath Intitute
  • CAMI Health

Please complete this brief form for inquiries about the MPT Product Development Database, MPT Priority Action Areas, MPT Funding Opportunities, and/or other MPT related questions.

  • This field is for validation purposes and should be left unchanged.